[Research Report] The fish vaccine market size was valued at US$ 355.88 million in 2022 and is projected to reach US$ 617.38 million by 2030. It is estimated to grow at a CAGR of 7.1% during 2022–2030.
Market Insights and Analyst View:
The fish vaccine market size is increasing with growing government initiatives to develop the aquaculture industry and surging demand for aquatic animal-derived food. Additionally, the development of novel fish vaccines in the market is expected to create ample opportunities for the fish vaccine market. Fish vaccine has come a long way in recent years due to advancements in research and technology. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Scientific and technological advancements have opened up newer avenues in the basic and applied research fields of aquatic vaccines.
Growth Drivers and Challenges:
Aquaculture grows exponentially due to the high demand for seafood and decreasing annual catch of wild fish. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. For instance, in February 2021, the Foundation for Food & Agriculture Research (FFAR) funded US$ 790,326 to create a delivery system for a vaccine that can help stop the tilapia lake virus and other diseases from spreading in the aquaculture sector.
An unhealthy diet is a growing concern in developing and developed countries, resulting in a variety of adverse health consequences. Thus, fish is highly advisable in the diet for healthy growth and development, as it is rich in vitamins, minerals, lipids, and macronutrients such as proteins. Additionally, it is believed that aquaculture is the most effective way to produce high-quality proteins for a sustainable human diet.
The development of an effective mucosal vaccine while strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses globally to regularize fish vaccination processes. Thus, the development of novel fish vaccines is likely to create significant opportunities for the market growth.
The use of fish vaccine must be approved by an appropriate authority in the nation or region where it will be used. Prior to any use or trade, it is mandatory to follow specific rules and recommendations set by relevant competent authorities. The legislation, requirements, and involved regulatory bodies for authorization and use may vary by country. A national competent authority in the EU cannot authorize fish vaccines. The European Medicines Agency authorizes them for the entire European Union. The cost of producing vaccines is high as the EU has strict guidelines for vaccine manufacturers regarding good manufacturing practices (GMP). Fish vaccines have a smaller market than vaccines for other animal species, and their development costs are higher than those of vaccines for other animal species. In the US, the FDA approves fish vaccines. The development of fish vaccines takes 10 years or longer and costs US$ 10–20 million. Thus, stringent government regulations hinder the market growth.
Emergence of disease outbreak caused by parasites, viruses, and bacteria have slowed down the evolution of the global aquaculture industry for several decades. Aside from being harmful to human health, emerging diseases have a significant impact on aquatic animals. Traditional vaccines have limitations and drawbacks, which bolsters the demand for the development of novel advanced vaccines such as chimeric multiepitope vaccines. Newer avenues in the basic and applied research fields of aquatic vaccines have been opened up by scientific and technological advancements. An effort has been made to create novel aquatic vaccines with higher quality and efficiency using new technologies, approaches, and strategies.
Using the available bioinformatics tools and current knowledge of immunoproteomics and genomics, researchers can identify potential targeted epitopes that immune cells can recognize. Further, as the cost of techniques such as whole genome sequencing continues to decline, it opens the way for species-specific vaccine development. This is likely to boost investments in developing new vaccines. In 2021, the Central Institute of Brackishwater Aquaculture (ICAR) launched a recombinant vaccine against viral nervous necrosis (VNN) in India.
Thus, the development of an effective mucosal vaccine with strengthening the administration process is expected to accelerate the novel vaccine development, which would boost the aquaculture businesses in Mediterranean countries to regularize fish vaccination processes. Hence, development of novel fish vaccines is likely creating significant opportunity for market growth
Diversifying into new fish species, particularly marine fish, is a trend in the aquaculture sector. Farms across the world are increasingly relying on vaccinations to manage animal health. The development of novel pathogens with extensive antigenic diversity may also reduce the effectiveness of conventional vaccines. This motivates vaccine researchers to look into new techniques for creating potent vaccines for aquaculture. Subunit or recombinant DNA/RNA particle vaccines may have been created using modern vaccine technology, which is focused on specific pathogen components. Finding new vaccine candidates to fight fish pathogens such as mycotic and parasitic agents is made possible by recent advancements in vaccines and vaccinology. The development and production of fish vaccines can done rapidly with the help of new techniques in genetics, immunology, and biotechnology. These techniques include the use of genetically engineered vectors, recombinant vaccines, and DNA vaccines.
DNA vaccine technology provides significant protection against fish diseases. Targeting the construct and/or transgene to antigen-receptor cells is a promising way to improve the DNA vaccine's effectiveness against other viral diseases. Molecular assemblies can be used to target dendritic cells (DC) and antigen-presenting cells (APC) in DNA vaccines, producing immune responses as a result. Another tactic is to encapsulate the DNA vaccine in specific carriers to increase transgene and MHC expression.
The development of novel vaccines known as recombinant DNA-based vaccine or new-generation vaccines has made extensive use of R DNA technology. Recombinant immunogenic protein vaccines or epitopes purified from vectors carrying the gene of interest produced in prokaryotic or eukaryotic expression systems, peptide vaccines, live vaccines produced by defined genetic manipulations, and microbial vectors carrying gene coding for immunogenic protein and DNA vaccines are among the types of vaccines based on recombinant DNA technology that have been developed. Recombinant vaccines have the advantage of closely simulating naturally occurring infections, which aids in triggering a potent immune response in the treated fish.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fish Vaccine Market: Strategic Insights
Market Size Value in US$ 355.88 million in 2022 Market Size Value by US$ 617.38 million by 2030 Growth rate CAGR of 7.1% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fish Vaccine Market: Strategic Insights
| Market Size Value in | US$ 355.88 million in 2022 |
| Market Size Value by | US$ 617.38 million by 2030 |
| Growth rate | CAGR of 7.1% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The fish vaccine market is divided on the basis of vaccine type, application, route of administration, and species. Based on vaccine type, the fish vaccine market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on application, the fish vaccine market is segmented into bacterial, viral, and parasitic. Based on route of administration, the fish vaccine market is classified into injected, immersion, and oral. Based on species, the fish vaccine market is segmented into salmon, trout, tilapia, and others. Based on geography, the fish vaccine market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Segmental Analysis:
Based on vaccine type, the fish vaccine market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccines, and others. After being administered to aquatic animals, inactivated vaccines still maintain their immunogenicity and lead to specific resistance in those animals. Inactivated vaccines use physical or chemical methods to inactivate highly virulent pathogenic microorganisms. The use of ultraviolet light, high-temperature heating, ultrasound, and G-ray are examples of physical inactivation techniques. Chemical inactivation is the process of making harmful bacteria dormant by using chemicals to break down their nucleic acids or proteins. In contrast to chemical inactivation, which is the most widely used form of inactivation, physical inactivation is difficult, expensive, constrained, and unstable. Inactivated vaccines help combat the spread of bacterial diseases such as Vibriosis, Tenacibaculosis, and Francisellosis. There are various advantages of inactivated vaccines, such as easy to prepare, store, and transport, as well as a high level of safety and stability of immunogenicity.
The availability of inactivated fish vaccines in various countries/regions is anticipated to fuel the growth of the segment. For instance, inactivated vaccines offered by Merck Animal Health, MSD Animal Health, Pharmaq, Aquavac-vaccines, and hipara are approved by the US FDA for various fish diseases such as Vibriosis, Furunculosis, Enteric septicemia of catfish (ESC), and Pasteurellosis. These vaccines are available in different regions/countries, such as the US, Canada, Japan, Europe, Australia, Chile, Vietnam, Taiwan, Japan, Brazil, Indonesia, Norway, the UK, Ireland, and Iceland.
Fish Vaccine Market, by Vaccine Type – 2022 and 2030
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Based on the application, the fish vaccine market is classified into bacterial, viral, and parasitic. In 2022, the bacterial segment held the largest share of the market and is expected to register the highest CAGR during 2022–2030. Poor water quality, organic loading of the aquatic environment, improper handling and transport of fish, and significant temperature changes frequently cause bacterial diseases in fish, which consequently drives the need for vaccines that can help treat bacterial infections in fish.
Based on route of administration, the fish vaccine market is classified into injected, immersion, and oral. In 2022, the injected segment held the largest share of the market. The immersion segment is expected to register the highest CAGR during 2022–2030.
Based on species, the fish vaccine market is classified into salmon, trout, tilapia, and others. In 2022, the salmon segment held the largest share of the market. The others segment is expected to register the highest CAGR during 2022–2030.
Regional Analysis:
Based on geography, the fish vaccine market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the fish vaccine market, and Asia Pacific is expected to be the fastest-growing market in the coming years. The market growth in North America is attributed to the increase in aquaculture vaccines in the US. For instance, according to the World Bank, the US produced ~448 thousand metric ton of aquaculture vaccines. As per the same source, about 5.6 million fish were produced in 2021 in North America, of which ~4.7 million is produced in the US, which is ~83% of the total region. The ongoing research related to the immune system of fish for developing vaccines with higher efficacy is fuelling the growth of the market in Mexico. For instance, in December 2022, researchers at Salinas Lab in The University of New Mexico’s Department of Biology discovered an immune structure in the rainbow trout’s nasal cavity, which will help understand the efficacy of the vaccine given to the trout.
Competitive Landscape and Key Companies:
Zoetis Inc., Merck & Co Inc., Hipra SA, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories, Elanco Animal Health Inc., Nisseiken Co., Ltd., KBNP Inc., Choong Ang Vaccine Laboratories Co., Ltd., and INDIAN IMMUNOLOGICALS LTD. are a few prominent players operating in the fish vaccine market. These companies focus on expanding service offerings to meet the growing consumer demand worldwide. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Vaccine Type, Application, Route of Administration, Species, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Vaccination is a quick, efficient, and preventative method of disease prevention for fish. Through the administration of vaccines, a protective immune response is induced in an animal during vaccination.
The fish vaccine market majorly consists of the players such as Zoetis Inc., Merck & Co Inc., Hipra SA, Phibro Animal Health Corp, Vaxxinova International BV, Kyoto Biken Laboratories, Elanco Animal Health Inc., Nisseiken Co., Ltd., KBNP Inc., Choong Ang Vaccine Laboratories Co., Ltd., and INDIAN IMMUNOLOGICALS LTD.
North America region is dominating the fish vaccine market in terms of market share and Asia Pacific is anticipated to register the highest CAGR during 2022-2030.
The fish vaccine market is analyzed on the basis of vaccine type, application, route of administration, and species. Based on product, the market is segmented into inactivated vaccines, live vaccines, subunit vaccines, recombinant vector vaccine, and others. Based on application, the market is classified as bacterial, viral, and parasitic. Based on route of administration, the market is segmented into injected, immersion, and oral. Based on species, the market is classified into salmon, trout, tilapia, and others
The growth of the global fish vaccine market is attributed to a few key factors, such as the government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Fish Vaccine Market, by Geography
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Fish Vaccine Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Fish Vaccine Market - Key Industry Dynamics
5.1 Market Drivers:
5.1.1 Government Initiatives to Develop Aquaculture Industry
5.1.2 Surging Demand for Aquatic Animal-Derived Food Products
5.2 Market Restraints
5.2.1 Stringent Regulations for Approval of Vaccine
5.3 Market Opportunities
5.3.1 Development of Novel Fish Vaccine
5.4 Future Trends
5.4.1 Technological Advancements in Fish Vaccine
5.5 Impact Analysis:
6. Fish Vaccine Market - Global Market Analysis
6.1 Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
7. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Live Vaccines
7.4.1 Overview
7.4.2 Live Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Subunit Vaccines
7.5.1 Overview
7.5.2 Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.6 Recombinant Vector Vaccine
7.6.1 Overview
7.6.2 Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.7 Others
7.7.1 Overview
7.7.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Application
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
8.3 Bacterial
8.3.1 Overview
8.3.2 Bacterial: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.4 Viral
8.4.1 Overview
8.4.2 Viral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.5 Parasitic
8.5.1 Overview
8.5.2 Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
9.3 Injected
9.3.1 Overview
9.3.2 Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Immersion
9.4.1 Overview
9.4.2 Immersion: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.5 Oral
9.5.1 Overview
9.5.2 Oral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10. Global Fish Vaccine Market – Revenue and Forecast to 2030 – by Species
10.1 Overview
10.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
10.3 Salmon
10.3.1 Overview
10.3.2 Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.4 Trout
10.4.1 Overview
10.4.2 Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.5 Tilapia
10.5.1 Overview
10.5.2 Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10.6 Others
10.6.1 Overview
10.6.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
11. Fish Vaccine Market - Geographical Analysis
11.1 North America Fish Vaccine Market, Revenue and Forecast To 2030
11.1.1 Overview
11.1.2 North America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.3 North America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.4 North America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.5 North America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.6 North America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7 North America Fish Vaccine Market, by Country
11.1.7.1 US
11.1.7.1.1 Overview
11.1.7.1.2 US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.1.3 US: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.1.4 US: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.1.5 US: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.1.6 US: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7.2 Canada
11.1.7.2.1 Overview
11.1.7.2.2 Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.2.3 Canada: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.2.4 Canada: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.2.5 Canada: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.2.6 Canada: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.1.7.3 Mexico
11.1.7.3.1 Overview
11.1.7.3.2 Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.1.7.3.3 Mexico: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.1.7.3.4 Mexico: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.1.7.3.5 Mexico: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.1.7.3.6 Mexico: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2 Europe Fish Vaccine Market, Revenue and Forecast to 2030
11.2.1 Overview
11.2.2 Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.3 Europe: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.4 Europe: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.5 Europe: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.6 Europe: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7 Europe Fish Vaccine Market, by Country
11.2.7.1 UK
11.2.7.1.1 Overview
11.2.7.1.2 UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.1.3 UK: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.1.4 UK: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.1.5 UK: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.1.6 UK: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.2 Germany
11.2.7.2.1 Overview
11.2.7.2.2 Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.2.3 Germany: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.2.4 Germany: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.2.5 Germany: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.2.6 Germany: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.3 France
11.2.7.3.1 Overview
11.2.7.3.2 France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.3.3 France: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.3.4 France: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.3.5 France: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.3.6 France: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.4 Italy
11.2.7.4.1 Overview
11.2.7.4.2 Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.4.3 Italy: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.4.4 Italy: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.4.5 Italy: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.4.6 Italy: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.5 Spain
11.2.7.5.1 Overview
11.2.7.5.2 Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.5.3 Spain: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.5.4 Spain: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.5.5 Spain: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.5.6 Spain: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.2.7.6 Rest of Europe
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.2.7.6.3 Rest of Europe: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.2.7.6.4 Rest of Europe: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.2.7.6.5 Rest of Europe: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.2.7.6.6 Rest of Europe: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3 Asia Pacific Fish Vaccine Market, Revenue and Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.3 Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.4 Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.5 Asia Pacific: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.6 Asia Pacific: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7 Asia Pacific Fish Vaccine Market, by Country
11.3.7.1 China
11.3.7.1.1 Overview
11.3.7.1.2 China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.1.3 China: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.1.4 China: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.1.5 China: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.1.6 China: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.2 Japan
11.3.7.2.1 Overview
11.3.7.2.2 Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.2.3 Japan: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.2.4 Japan: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.2.5 Japan: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.2.6 Japan: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.3 India
11.3.7.3.1 Overview
11.3.7.3.2 India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.3.3 India: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.3.4 India: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.3.5 India: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.3.6 India: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.4 Australia
11.3.7.4.1 Overview
11.3.7.4.2 Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.4.3 Australia: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.4.4 Australia: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.4.5 Australia: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.4.6 Australia: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.5 South Korea
11.3.7.5.1 Overview
11.3.7.5.2 South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.5.3 South Korea: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.5.4 South Korea: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.5.5 South Korea: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.5.6 South Korea: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.3.7.6 Rest of Asia Pacific
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.3.7.6.3 Rest of Asia Pacific: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.3.7.6.4 Rest of Asia Pacific: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.3.7.6.5 Rest of Asia Pacific: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.3.7.6.6 Rest of Asia Pacific: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4 Middle East & Africa Fish Vaccine Market, Revenue and Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.3 Middle East & Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.4 Middle East & Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.5 Middle East & Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6 Middle East & Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.1 Middle East & Africa Fish Vaccine Market, by Country
11.4.6.2 Saudi Arabia
11.4.6.2.1 Overview
11.4.6.2.2 Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.2.3 Saudi Arabia: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.2.4 Saudi Arabia: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.2.5 Saudi Arabia: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.2.6 Saudi Arabia: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.3 South Africa
11.4.6.3.1 Overview
11.4.6.3.2 South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.3.3 South Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.3.4 South Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.3.5 South Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.3.6 South Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.4 UAE
11.4.6.4.1 Overview
11.4.6.4.2 UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.4.3 UAE: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.4.4 UAE: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.4.5 UAE: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.4.6 UAE: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.4.6.5 Rest of Middle East Africa
11.4.6.5.1 Overview
11.4.6.5.2 Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.4.6.5.3 Rest of Middle East Africa: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.4.6.5.4 Rest of Middle East Africa: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.4.6.5.5 Rest of Middle East Africa: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.4.6.5.6 Rest of Middle East Africa: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5 South & Central America Fish Vaccine Market, Revenue and Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.3 South & Central America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.4 South & Central America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.5 South & Central America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.6 South & Central America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7 South & Central America Fish Vaccine Market, by Country
11.5.7.1 Brazil
11.5.7.1.1 Overview
11.5.7.1.2 Brazil Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.1.3 Brazil: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.1.4 Brazil: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.1.5 Brazil: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.1.6 Brazil: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7.2 Argentina
11.5.7.2.1 Overview
11.5.7.2.2 Argentina Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.2.3 Argentina: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.2.4 Argentina: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.2.5 Argentina: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.2.6 Argentina: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
11.5.7.3 Rest of South & Central America
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
11.5.7.3.3 Rest of South & Central America: Fish Vaccine Market, by Vaccine Type, 2020–2030 (US$ Thousand)
11.5.7.3.4 Rest of South & Central America: Fish Vaccine Market, by Route of Administration, 2020–2030 (US$ Thousand)
11.5.7.3.5 Rest of South & Central America: Fish Vaccine Market, by Species, 2020–2030 (US$ Thousand)
11.5.7.3.6 Rest of South & Central America: Fish Vaccine Market, by Application, 2020–2030 (US$ Thousand)
12. Fish Vaccine Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in Fish Vaccine Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Zoetis Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck & Co Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 HIPRA SA
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Phibro Animal Health Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Vaxxinova International BV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Kyoto Biken Laboratories Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Elanco Animal Health Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nisseiken Co Ltd
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 KBNP Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Choong Ang Vaccine Laboratory
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Indian Immunologicals Ltd
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
List of Tables
Table 1. Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. North America Fish Vaccine Market, by Vaccine Type– Revenue and Forecast to 2030 (US$ Thousand)
Table 8. North America Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 9. North America Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 10. North America Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 11. US Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 12. US Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 13. US Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 14. US Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 15. Canada Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 16. Canada Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 17. Canada Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 18. Canada Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Mexico Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Mexico Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Mexico Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Mexico Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 23. Europe Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 24. Europe Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 25. Europe Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 26. Europe Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 27. UK Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 28. UK Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 29. UK Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 30. UK Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 31. Germany Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 32. Germany Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 33. Germany Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 34. Germany Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 35. France Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 36. France Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 37. France Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 38. France Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 39. Italy Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 40. Italy Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 41. Italy Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 42. Italy Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 43. Spain Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 44. Spain Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 45. Spain Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 46. Spain Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 47. Rest of Europe Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 48. Rest of Europe Fish Vaccine Market, by Route of Administration– Revenue and Forecast to 2030 (US$ Thousand)
Table 49. Rest of Europe Fish Vaccine Market, by Species– Revenue and Forecast to 2030 (US$ Thousand)
Table 50. Rest of Europe Fish Vaccine Market, by Application– Revenue and Forecast to 2030 (US$ Thousand)
Table 51. Asia Pacific Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 52. Asia Pacific Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 53. Asia Pacific Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 54. Asia Pacific Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 55. China Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 56. China Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 57. China Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 58. China Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 59. Japan Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 60. Japan Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 61. Japan Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 62. Japan Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 63. India Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 64. India Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 65. India Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 66. India Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 67. Australia Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 68. Australia Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 69. Australia Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 70. Australia Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 71. South Korea Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 72. South Korea Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 73. South Korea Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 74. South Korea Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 75. Rest of Asia Pacific Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 76. Rest of Asia Pacific Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 77. Rest of Asia Pacific Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 78. Rest of Asia Pacific Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 79. Middle East & Africa Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 80. Middle East & Africa Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 81. Middle East & Africa Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 82. Middle East & Africa Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 83. Saudi Arabia Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 84. Saudi Arabia Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 85. Saudi Arabia Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 86. Saudi Arabia Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 87. South Africa Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 88. South Africa Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 89. South Africa Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 90. South Africa Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 91. UAE Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 92. UAE Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 93. UAE Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 94. UAE Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 95. Rest of Middle East Africa Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 96. Rest of Middle East Africa Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 97. Rest of Middle East Africa Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 98. Rest of Middle East Africa Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 99. South & Central America Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 100. South & Central America Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 101. South & Central America Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 102. South & Central America Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 103. Brazil Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 104. Brazil Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 105. Brazil Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 106. Brazil Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 107. Argentina Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 108. Argentina Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 109. Argentina Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 110. Argentina Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 111. Rest of South & Central America Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 112. Rest of South & Central America Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 113. Rest of South & Central America Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 114. Rest of South & Central America Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 115. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 116. Recent Organic Growth Strategies in Fish Vaccine Market
Table 117. Glossary of Terms, Fish Vaccine Market
List of Figures
Figure 1. Fish Vaccine Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. Fish Vaccine Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
Figure 6. Fish Vaccine Market Revenue, Geography (US$ Th), 2022 – 2030
Figure 7. Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 8. Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Live Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 12. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 14. Bacterial: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Viral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 16. Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 18. Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Immersion: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 20. Oral: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 22. Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 25. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 26. North America: Fish Vaccine Market, by Key Country – Revenue (2022) (US$ Thousand)
Figure 27. North America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. North America Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 29. US Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. Canada Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 31. Mexico Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 32. Europe Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 33. Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 34. Europe Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 35. UK Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 36. Germany Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 37. France Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 38. Italy Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 39. Spain Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 40. Rest of Europe Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 41. Asia Pacific Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 42. Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 43. Asia Pacific Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 44. China Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 45. Japan Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 46. India Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 47. Australia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 48. South Korea Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 49. Rest of Asia Pacific Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 50. Middle East & Africa Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 51. Middle East & Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 52. Middle East & Africa Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 53. Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 54. South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 55. UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 56. Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 57. South & Central America Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 58. South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 59. South & Central America Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 60. Brazil Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 61. Argentina Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 62. Rest of South & Central America Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 63. Growth Strategies in Fish Vaccine Market
The List of Companies - Fish Vaccine Market
- Zoetis Inc
- Merck & Co Inc
- Hipra SA
- Phibro Animal Health Corp
- Vaxxinova International BV
- Kyoto Biken Laboratories
- Elanco Animal Health Inc
- Nisseiken Co., Ltd.
- KBNP Inc
- Choong Ang Vaccine Laboratories Co., Ltd.
- INDIAN IMMUNOLOGICALS LTD
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Fish Vaccine Market
Sep 2023
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2023
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2023
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2023
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2023
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2023
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2023
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2023